Clinical Trial Update: A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 1/2 study of ASN-002 in adults with low-risk nodular basal cell carcinoma, focusing on efficacy and safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Basal Cell Nevus Syndrome
• Nodular Basal Cell Carcinoma
• Skin Neoplasm

Drugs mentioned

• ASN-002

Snippet

Sponsor: Ascend Biopharmaceuticals Ltd | Conditions: Basal Cell Nevus Syndrome, Skin Neoplasm | Phase 1, Phase 2 | Status: COMPLETED